Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term survival.

Y W Cho, P I Terasaki

    Clinical Transplants
    |January 1, 1988
    PubMed
    Summary
    This summary is machine-generated.

    Kidney transplant half-life varies significantly by donor type, with HLA identical sibling donors offering the longest graft survival. Recipient race impacts outcomes, with white recipients showing improved half-life while black recipients experienced a decline.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Landsteiner Award. HLA epitope matching.

    Transfusion·1992
    Same author

    HLA matching effect on five-year graft survival and half-life in the cyclosporine era.

    Kidney international. Supplement·1992
    Same author

    Prolongation of second heart transplants in rats.

    Transplantation·1992
    Same author

    Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.

    The New England journal of medicine·1992
    Same author

    Effect of mismatching serologically defined residues on kidney transplant survival.

    Transplantation proceedings·1992
    Same author

    Beneficial effect of sharing six-antigen-matched cadaver kidneys in the United States.

    Transplantation proceedings·1992
    Same journal

    Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.

    Clinical transplants·2017
    Same journal

    Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients.

    Clinical transplants·2017
    Same journal

    From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.

    Clinical transplants·2017
    Same journal

    Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.

    Clinical transplants·2017
    Same journal

    Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD).

    Clinical transplants·2017
    Same journal

    C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.

    Clinical transplants·2017
    See all related articles

    Area of Science:

    • Nephrology
    • Immunology
    • Transplantation Medicine

    Background:

    • Kidney transplantation is a vital treatment for end-stage renal disease.
    • Graft survival rates are influenced by numerous donor and recipient factors.
    • Understanding these factors is crucial for optimizing transplant outcomes.

    Purpose of the Study:

    • To analyze the long-term graft survival (half-life) of kidney transplants.
    • To identify key factors influencing kidney transplant half-life, including donor type, recipient characteristics, and HLA matching.
    • To evaluate trends in kidney transplant half-life over time.

    Main Methods:

    • Retrospective analysis of kidney transplant data from 1971 to 1986.
    • Calculation of graft half-life based on donor type (cadaver, parental, sibling), recipient demographics (race, age), cold ischemia time (CIT), and HLA matching (A, B, and DR loci).

    Related Experiment Videos

    Main Results:

    • HLA identical sibling donor transplants demonstrated the longest half-life (19.1-26.5 years), followed by parental donors (9.3-11.8 years).
    • Cadaver donor grafts had shorter half-lives (6.6-7.5 years for first, 5.1-6.5 years for second).
    • White recipients showed improved half-life (7.7 to 9.3 years), while black recipients experienced a decrease (5.4 to 3.5 years). HLA matching significantly impacted survival, with fewer mismatches correlating to longer half-life.

    Conclusions:

    • Donor type and HLA compatibility are critical determinants of long-term kidney transplant success.
    • Disparities in graft survival based on recipient race warrant further investigation.
    • Optimizing cold ischemia time and HLA matching strategies can potentially improve transplant outcomes.